Quick Takeaways
- L1 Capital Global Opportunities Master Fund, Ltd. filed SCHEDULE 13G for Aptevo Therapeutics Inc. Common Stock (APVO).
- Disclosed ownership: 6.2%.
- Date of event: 02 Apr 2025.
L1 Capital Global Opportunities Master Fund, Ltd. - 02 Apr 2025 SCHEDULE 13G Report for Aptevo Therapeutics Inc. Common Stock (APVO)
- Filing Manager
- L1 Capital Global Opportunities Master Fund, Ltd.
- Reporting Manager
- L1 Capital Global Opportunities Master Fund, Ltd.
- Symbol
- APVO
- Shares outstanding
- 3,220,612 shares
- Disclosed Ownership
- 200,000 shares
- Ownership
- 6.2%
- Form type
- SCHEDULE 13G
- Filing time
- 07 Apr 2025, 16:51:15 UTC
- Date of event
- 02 Apr 2025
- Next filing
- 25 Apr 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"L1 Capital Global Opportunities Master Fund, Ltd. disclosed 6.2% ownership in Aptevo Therapeutics Inc. Common Stock (APVO) on 02 Apr 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 07 Apr 2025, 16:51.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| L1 Capital Global Opportunities Master Fund, Ltd. | 6.2% | 200,000 | 200,000 | 0 | /s/ David Feldman | David Feldman, Director |